Qube Research & Technologies (QRT)
AUTL

Qube Research & Technologies (QRT)’s Autolus Therapeutics AUTL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,188
Closed -$79.3K – 3544
2025
Q1 		$79.3K Sell
51,188
-107,497
-68% -$218K ﹤0.01% 3036
2024
Q4 		$373K Sell
158,685
-206,310
-57% -$697K ﹤0.01% 2617
2024
Q3 		$1.32M Sell
364,995
-437,086
-54% -$1.74M ﹤0.01% 1927
2024
Q2 		$2.79M Buy
802,081
+753,506
+1,551% +$3.25M ﹤0.01% 1490
2024
Q1 		$310K Buy
48,575
+46,622
+2,387% +$291K ﹤0.01% 2792
2023
Q4 		$12.6K Sell
1,953
-8,315
-81% -$31.7K ﹤0.01% 3566
2023
Q3 		$23.9K Sell
10,268
-11,639
-53% -$33.2K ﹤0.01% 3096
2023
Q2 		$52.1K Buy
+21,907
New +$52K ﹤0.01% 2068

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return